Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of Feb 16
 +1.14 / +0.94%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 157.50, with a high estimate of 205.00 and a low estimate of 56.00. The median estimate represents a +28.17% increase from the last price of 122.88.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.18%
Growthannually -10.36%


Growthquarterly 21.55%
Growthannually 50.17%
Key to the earnings and sales forecast charts.